Tuesday, June 30, 2015 1:15:47 PM
500 Hazelwood
RoadVenice Florida 34293 USA
COMPANY STATEMENT
FROM: JOHN MEREDITH, CFO & DIRECTOR, Therapy Cells, Inc
We have been actively engaged in negotiations regarding the required funding for the Company as stated in the last quarterly Financial Statements posted on the OTC website.
Whilst those negotiations have been successfully concluded and a long- term relationship entered into, there have been a number of problems regarding the mechanics and logistics of the agreement – some have been local in nature and others as a result of global influences – all of which have been beyond our control.
We had hoped that the funding would be received by today and indicated as such in previous
releases; the funding has now been delayed a further month and we have been given assurances that this deadline will be met.
The Board is, naturally, disappointed but we remain positive that
the process for FDA approval can start in the very near future. As soon as we have any news we will issue a further statement.
Venice, Florida
June 30th, 2015
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM